Cornercap Investment Counsel Inc Regeneron Pharmaceuticals, Inc. Transaction History

Cornercap Investment Counsel Inc

  • $329 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $790,172 - $1.06 Million
-1,441 Closed
0 $0
Q1 2022

May 10, 2022
BUY
$595.12 - $698.43 $857,567 - $1.01 Million
1,441 New
1,441 $1.01 Million
Q1 2019

May 15, 2019
SELL
$372.08 - $439.57 $2.82 Million - $3.33 Million
-7,574 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$335.82 - $403.04 $2.54 Million - $3.05 Million
7,574 New
7,574 $2.83 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email